Enterprise Value
18.31M
Cash
56.26M
Avg Qtr Burn
-20.9M
Short % of Float
0.34%
Insider Ownership
7.28%
Institutional Own.
46.03%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
SRF388 (IL-27) Details Solid tumor/s, Cancer | Phase 2 Update | |
SRF114 Details Solid tumor/s, Cancer | Phase 1/2 Data readout | |
NZV930 (CD73) Details Solid tumor/s, Cancer | Phase 1 Data readout | |
GSK4381562 Details Solid tumor/s, Cancer | Phase 1 Data readout | |
SRF617 (CD39) Details Solid tumor/s, Cancer | Failed Discontinued |